KOERS GALAPAGOS 2015

16.480 Posts, Pagina: « 1 2 3 4 5 6 ... 817 818 819 820 821 822 823 824 » | Laatste
[verwijderd]
0
quote:

Glycostem tech schreef op 2 augustus 2015 18:22:


As midsize investor we are careful with GLPG and sold a large position end of last week. We all know the Pfizer story regarding Xeljanz (tofacitinib) - which is comparable to filgotinib as a JAK- inhibitor. Although, now approved by the FDA for the US market - European approval was turned down due to overall safety concerns and serious side effects. So far, in Darwin studies there are less than 600 patients only (including low dose and placebo groups) and already one death in the verum group due to pneumonia ! Approval for tofacitinib was denied in the EU after records of 3300 patient files were submitted - and benefits of this drug did not outweigh the risks (immunosuppression, liver damage, cancer and gastro-intestinal perforations). Pfizer shares dropped 3% after the announcement of 4 tofacitinib related death in 2011. Galapagos market value heavily depends (at least at the moment) on this single drug - all others are still too far from market.
One should think about it.

The cause of death was not relatable to filgotinib.. people die every day.

Can you show us the phase two 24 week results of tofacitinib ?

It doesnt make sense saying something is comparable and not actually show the comparisons..
Gala-diner
0
quote:

Glycostem tech schreef op 2 augustus 2015 18:22:


As midsize investor we are careful with GLPG and sold a large position end of last week. We all know the Pfizer story regarding Xeljanz (tofacitinib) - which is comparable to filgotinib as a JAK- inhibitor. Although, now approved by the FDA for the US market - European approval was turned down due to overall safety concerns and serious side effects. So far, in Darwin studies there are less than 600 patients only (including low dose and placebo groups) and already one death in the verum group due to pneumonia ! Approval for tofacitinib was denied in the EU after records of 3300 patient files were submitted - and benefits of this drug did not outweigh the risks (immunosuppression, liver damage, cancer and gastro-intestinal perforations). Pfizer shares dropped 3% after the announcement of 4 tofacitinib related death in 2011. Galapagos market value heavily depends (at least at the moment) on this single drug - all others are still too far from market.
One should think about it.


Midsize investor who publish this in a forum, very funny :-))
So you sold and now you are so noble to warn other investors, also very funny :-)))
For a midsize investor you are pretty badly informed...
Maybe you should go back to the playground and return to play with the other kids..
aossa
0
Ik wist al niet zo goed waarom de koers op nasdaq de hoogte in ging en ook niet vanwaar de aandelen kwamen. Nu (betaald?) hier wat komen bashen en de koers naar beneden praten om opnieuw wat in te slaan en dan weer aandelen op nasdaq te kunnen verkopen, geleend of getransfereerd, what ever. Nou dat hebben we net nodig om angsthazen het veld in te jagen. Profiteer van de mogelijke dips zou ik zo zeggen. Succes gegarandeerd :-(

PS. kan jij Nederlands praten? Je zou meer succes kunnen hebben imo. Het valt namelijk minder op...
[verwijderd]
0
Glycostem tech

DETAILS

Lid sinds 31 jul 2015
Laatste bezoek 02 aug 2015
Aantal posts 2
Gegeven aanbevelingen 0
Ontvangen aanbevelingen 0
Aanbevelingen/Posts 0,0000
[verwijderd]
0
quote:

djyves schreef op 2 augustus 2015 12:06:


Verwachtingen voor Maandag 10 Augustus slotkoers (in Euro):
Grapesharvester 70
Springinhetveld 65,49
MtBaker 63.47
Wonderwoman 62,22
SJURMV 61,00
Gorden Gekko 60,05
Hee jij ook hier 58.25
Mooiweer 57.50
Alan B'stard 52-56+
Ruud Rubbers 59,00
mickjagger2 € 61,25
biffy € 56,43
djvyes € 55,00


Nagenoeg al deze mensen gaan morgen bestens bijkopen bij opening? Is toch een mooi rendement in ruim een week....
Gala-diner
0
quote:

mr. gala schreef op 2 augustus 2015 20:58:


[...]

Nagenoeg al deze mensen gaan morgen bestens bijkopen bij opening? Is toch een mooi rendement in ruim een week....


Heb al genoeg gekocht en ben niet zo hebberig, je moet tenslotte een ander ook wat gunnen, toch?
pardon
0
Ik kijk morgen wel hoeveel bestens orders er zijn,en hoeveel aandelen dat worden.Als er niemand wil verkopen word het dus een freeze.
Bogo
0
Verwachtingen voor Maandag 10 Augustus slotkoers (in Euro):
Grapesharvester 70
Springinhetveld 65,49
MtBaker 63.47
Wonderwoman 62,22
SJURMV 61,00
Gorden Gekko 60,05
Hee jij ook hier 58.25
Mooiweer 57.50
Alan B'stard 52-56+
Ruud Rubbers 59,00
mickjagger2 € 61,25
biffy € 56,43
djvyes € 55,00
Bogo € 58,85
[verwijderd]
0
MtBaker
0
Verwachtingen voor Maandag 10 Augustus slotkoers (in Euro):
Grapesharvester 70
Springinhetveld 65,49
MtBaker 63.47
Wonderwoman 62,22
mickjagger2 € 61,25
SJURMV 61,00
Gorden Gekko 60,05
Ruud rubbers 59
Bogo 58,55
Hee jij ook hier 58.25
Mooiweer 57.50
Biffy 56.43
Grrrrr PFFFFF zucht 56.2
Twinkletown 54,50 en 55,50
Djyves 53 en 55
Alan B'stard 52-56+
Cees01
0
quote:

MtBaker schreef op 2 augustus 2015 22:20:


Verwachtingen voor Maandag 10 Augustus slotkoers (in Euro):
Grapesharvester 70
Springinhetveld 65,49
MtBaker 63.47
Wonderwoman 62,22
mickjagger2 € 61,25
SJURMV 61,00
Gorden Gekko 60,05
Ruud rubbers 59
Bogo 58,55
Hee jij ook hier 58.25
Mooiweer 57.50
Biffy 56.43
Grrrrr PFFFFF zucht 56.2
Twinkletown 54,50 en 55,50
Cees01 53.85
Djyves 53 en 55
Alan B'stard 52-56+

Bogo
0
quote:

MtBaker schreef op 2 augustus 2015 22:20:


Verwachtingen voor Maandag 10 Augustus slotkoers (in Euro):
Grapesharvester 70
Springinhetveld 65,49
MtBaker 63.47
Wonderwoman 62,22
mickjagger2 € 61,25
SJURMV 61,00
Gorden Gekko 60,05
Ruud rubbers 59
Bogo 58,55
Hee jij ook hier 58.25
Mooiweer 57.50
Biffy 56.43
Grrrrr PFFFFF zucht 56.2
Twinkletown 54,50 en 55,50
Djyves 53 en 55
Alan B'stard 52-56+



Hey mr. Baker ik zie dat je mijn verwachting voor 10 augustus van € 58,85 veranderd heb in € 58,55 waarschijnlijk heb je alles handmatig veranderd en is daar de fout ontstaan, geeft niks hoor, ik vind het leuk dat je mij wil laten winnen maar dat doe ik liever op een eerlijke manier.
Even goede vrienden en mijn voorspelling is dus € 58,85 groet Bogo.
Investor68
0
quote:

Glycostem tech schreef op 2 augustus 2015 18:22:


As midsize investor we are careful with GLPG and sold a large position end of last week. We all know the Pfizer story regarding Xeljanz (tofacitinib) - which is comparable to filgotinib as a JAK- inhibitor. Although, now approved by the FDA for the US market - European approval was turned down due to overall safety concerns and serious side effects. So far, in Darwin studies there are less than 600 patients only (including low dose and placebo groups) and already one death in the verum group due to pneumonia ! Approval for tofacitinib was denied in the EU after records of 3300 patient files were submitted - and benefits of this drug did not outweigh the risks (immunosuppression, liver damage, cancer and gastro-intestinal perforations). Pfizer shares dropped 3% after the announcement of 4 tofacitinib related death in 2011. Galapagos market value heavily depends (at least at the moment) on this single drug - all others are still too far from market.
One should think about it.


As far as we know to this date, Filgotinib does not have any of the risks that you associated with tofacitinib such as "immunosuppression, liver damage, cancer and gastro-intestinal perforations." Therefore, your comment is actually misleading. You should not compare Filgotinib to Tofacitinib in the manner in which you did it. It is very unprofessional, given that you call yourself a "midsize investor." I suggest that you should do a better and more objective research on filgotinib. Galapagos has a lot of potential. If we take into account the major products in Galapagos' pipeline, I think that most fair-minded people would agree that Galapagos' current share price (60,65 dollars) is significantly undervalued. If Galapagos were to be an American company, with all the fantastic results the company has produced so far, it would have been trading at somewhere between 100 to 150 dollars by now. It seems as if European pharmaceutical companies tend to get lower valuations than their American counterparts and this is not fair. This practise must be corrected!
Gala-diner
0
quote:

Investor68 schreef op 3 augustus 2015 00:25:


[...vAs far as we know to this date, Filgotinib does not have any of the risks that you associated with tofacitinib such as "immunosuppression, liver damage, cancer and gastro-intestinal perforations." Therefore, your comment is actually misleading. You should not compare Filgotinib to Tofacitinib in the manner in which you did it. It is very unprofessional, given that you call yourself a "midsize investor." I suggest that you should do a better and more objective research on filgotinib. Galapagos has a lot of potential. If we take into account the major products in Galapagos' pipeline, I think that most fair-minded people would agree that Galapagos' current share price (60,65 dollars) is significantly undervalued. If Galapagos were to be an American company, with all the fantastic results the company has produced so far, it would have been trading at somewhere between 100 to 150 dollars by now. It seems as if European pharmaceutical companies tend to get lower valuations than their American counterparts and this is not fair. This practise must be corrected!


I just think this man/woman is really funny, by posting this bullshit..
Most of all I find it funny that this child thinks he/she can make this share go down...
Get a life and find a regular job, because investing is not gonna bring you any money...
Just buy a few Galapagos shares and you might earn a few euro's...(,maybe you van buy a share or two)
Nobody is gonna believe your bullshit...

[verwijderd]
0
aston.martin
0
quote:

mr. gala schreef op 3 augustus 2015 09:14:


Nog meer problemen met inloggen bij binck?




Jaja, je bent niet alleen met dat probleem

16.480 Posts, Pagina: « 1 2 3 4 5 6 ... 817 818 819 820 821 822 823 824 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Plaats een reactie

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 23 jul 2021 17:35
Koers 50,860
Verschil -0,430 (-0,84%)
Hoog 51,380
Laag 50,650
Volume 278.706
Volume gemiddeld 0
Volume gisteren 274.111